Regentis Biomaterials (RGNT) vs Retractable Technologies (RVP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Retractable Technologies is the larger company by market cap ($19.8 million vs $11.9 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RGNT | RVP |
|---|---|---|
| Share price | $1.70 | $0.662 |
| Market cap | $11.94M | $19.82M |
| 1-day change | +4.29% | -4.17% |
| YTD return | -74.78% | -14.03% |
| 1-year return | — | -28.04% |
| 5-year return | — | -92.76% |
| EPS (TTM) | $-2.46 | $-0.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.50 | $1.14 |
| 52-week low | $1.23 | $0.60 |
| Distance from 52-week high | -89.03% | -41.93% |
| Analyst consensus | none | — |
| Avg. price target upside | +488.24% | — |
| Average volume | 76.78K | 27.81K |
| Shares outstanding | 7.02M | 29.94M |
| Employees | — | 195 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Regentis Biomaterials
RGNT stock →Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee.
Healthcare · Medical Instruments & Supplies
About Retractable Technologies
RVP stock →Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
Healthcare · Medical Instruments & Supplies · 195 employees
RGNT vs RVP FAQ
Which is bigger, Regentis Biomaterials or Retractable Technologies?
Retractable Technologies (RVP) is larger, with a market capitalization of $19.82M compared with $11.94M for Regentis Biomaterials (RGNT).
Are Regentis Biomaterials and Retractable Technologies in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.